biotech / news / / Medical Xpress
Novo Nordisk has obtained approval for the pill form of its popular Wegovy anti-obesity drug.
The EU has approved an oral version of Novo Nordisk's Wegovy anti-obesity drug for adults.
KEY POINTS
- Wegovy's pill is the first oral GLP-1 treatment available for weight management in the EU.
- The injectable form of Wegovy remains available for patients 12 and older, unlike the pill.
- Novo Nordisk expects to begin selling the oral drug in more markets in the second quarter.
COMPANIES
Summarized by Newsio from Medical Xpress. How we summarize →